Q: Any thoughts on the recent quarterly results? Would you buy, sell or hold?
5i Research Answer:
EPS of 19c missed estimates of 19.8c; revenue of $249.3M missed estimates of $256.7M. EBITDA of $30M beat estimates by 3%. The dividend was raised 14%. Revenue did slip year over year due to a decrease in ABS revenue and product mix. EBITDA rose 2.6%. Considering tariff and economic uncertainty, the quarter was decent. We would like to see positive free cash (still in deficit). Two acquisitions post-quarter look good though, and the stock is quite cheap and acting quite well this year. We would see it as a HOLD but a BUY into any decent weakness not related to company news.